Anesthesia and Pain Management: Techniques and Practice by Maurizio Marandola & Alida Albante
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
10 
Anesthesia and Pain Management:  
Techniques and Practice 
Maurizio Marandola and Alida Albante 
“Sapienza” University – Policlinico Umberto I, Rome, 
Italy 
1. Introduction 
Surgery for pancreatic cancer (PC) is widely viewed as a complex procedure associated with 
considerable perioperative morbidity and mortality. Many aspects of surgery for pancreatic 
cancer, such as the extent of resection, the value of vascular resection, the use of laparoscopy 
and the importance of treatment at high-volume centers are currently under debate. PC is the 
fourth leading cause of cancer related mortality in the United States with an estimated 42500 
new cases and 35000 deaths from the disease each year (Jemal, 2009). Analysis of overall 
survival shows that the prognosis of PC is still quite poor despite the fact that 1-year survival 
has increased from 15.2% to 21.6% and 5-year survival has increased from 3% to 5% (ShaibYH 
et al., 2006). Surgery is the only chance of cure and the presence of negative resection margins 
of the primary tumor represent the strongest prognostic factor. Preoperative staging 
modalities include the combination of several imaging techniques such as computed 
tomography (CT scan), magnetic resonance imaging (MRI), endoscopic ultrasounds (EUS), 
staging laparoscopy and laparoscopic ultrasound which aim to identify patients with 
resectable disease. There is consensus that patients with distant metastases (liver, lung, 
peritoneum) or local invasion of the surrounding organs (stomach, colon, small bowel) are 
usually not surgical candidates. A decision analysis demonstrated that the best strategy to 
assess tumor resectability was based on CT as an initial test and the use of EUS to confirm the 
results of resectability by CT (Delbecke et al., 1999). Laparoscopic ultrasonography (LUS) has 
been introduced as an additional procedure to increase the detection of intrahepatic 
metastases, identify enlarged and suspicious lymph nodes and to evaluate local growth in the 
vascular structures (Tilleman et al., 2004). The routine use of staging laparoscopy and LUS in 
patients with radiographically resectable PC remains controversial as imaging modalities has 
significantly improved, thus reducing the risk of discovering non resectable disease at the time 
of surgery. Surgery for the PC can be considered an high-risk surgery. This term is rarely 
explicitly defined in scientific articles. There seems to be a common understanding among 
surgeons and anesthesiologists of what major surgery means. It can be defined as a surgical 
procedure that is extensive, involves removal of whole or parts of organs and/or is life-
threatening. It has also been defined as a surgical procedure with >1 mortality (Ghaferi et al., 
2009). One possibility of evaluating the perioperative risk is the use of 1 of several risk scores. 
The American Society of Anesthesiologists score is widely used and easy to apply, but 
excludes age from its risk analysis (Kullavanijaya et al., 2001). Age is securely one of the most 
important, if not the single most predictive, risk factors for morbidity and mortality after major 
surgery, including major pancreatic surgery (Riall et al., 2008). 
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2. Preanesthetic considerations 
Patients undergoing pancreatic surgey require a complete history and physical examination. 
Coexisting medical illnesses may complicate the surgical and anesthetic course. The 
objectives of the preanesthetic evaluation include establishing a doctor-patient relationship, 
becoming familiar with the surgical illness and coexisting medical conditions, developing a 
management strategy for perioperative anesthetic care and obtaining informed consent for 
the anesthetic plan. 
2.1 History of smoking 
The risk of PC in smokers ranks second to lung cancer and is proportionate to the frequency, 
duration and cumulative smoking dose (Lynch et al., 2009; Neugut et el., 1995). The patients 
who smoke have an increased risk of intra- and postoperative complications, particularly of 
a pulmonary or cardiovascular nature, compared with nonsmoking patients (Bluman et al., 
1998; Myles et al., 2002). As carbon monoxide (CO) preferentially binds to hemoglobin in 
place of oxygen, the short-term effects of cigarette smoking include elevated blood CO levels 
that result in a 3% to 12% reduction of oxygen availability in the periphery (Pearce & Jones, 
1984). Moreover, nicotine stimulates a surgical stress response with increase in heart rate, 
arterial blood pressure and peripheral vascular resistance. Postoperative pulmonary 
complications are an important part of the risk of surgery and prolong the hospital stay by 
an average of one to two weeks. A careful history taking and physical examination are the 
most important parts of preoperative pulmonary risk assessment. One should seek a history 
of exercise intolerance, chronic cough or dyspnea. The physical examination may identify  
PREOPERATIVE 
Encourage cessation of cigarette smoking for at least 8 wk 
Treat airflow obstruction in patients with chronic obstructive pulmonary disease or 
asthma 
Administer antibiotics and delay surgery if respiratory infection is present 
Begin patient education regarding lung-expansion maneuvers 
 
INTRAOPERATIVE 
 
Limit duration of surgery to less than 3 hr 
Use spinal or epidural anesthesia 
Use laparoscopic procedures when possible 
Substitute less ambitious procedure for upper abdominal or thoracic surgery when 
possible 
 
POSTOPERATIVE 
 
Use deep-breathing exercises or incentive spirometry 
Use continuous positive airway pressure 
Use epidural analgesia 
Use intercostal nerve blocks 
Table 1. Risk-Reduction strategies  
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decreased breath sounds, dullness to percussion, wheezes, rhonchi and a prolonged 
expiratory phase that can predict an increase in the risk of pulmonary complications 
(Lawrence et al., 1996). The value of routine preoperative pulmonary testing remains 
controversial. There is consensus that such testing should be performed selectively in 
patients undergoing no-lung resection. It has been suggested that an increased risk of 
pulmonary complications is associated with a forced expiratory volume in one second 
(FEV1) or forced vital capacity (FVC) of less than 70 percent of the predicted value or a ratio 
of FEV1 to FVC of less than 65 percent (Gass & Olsen, 1986). A partial pressure of arterial 
carbon dioxide (PaCO2) greater than 45 mmHg can’t be considered as a risk factor for 
pulmonary complications. Several strategies can be adopted in the perioperative period 
reducing the risks of complications (Table 1). 
2.2 Diabetes 
Nearly 80% of PC patients have either frank diabetes or impaired glucose tolerance. 
Diabetes is usually diagnosed either concomitantly or during the two years preceding the 
diagnosis (Gullo et al. 1994; Permet et al. 1993). The link between abnormal glucose and PC 
exists only for type II diabetes. Better glycaemic control in diabetic patients undergoing 
major surgery has been shown to improve perioperative mortality and morbidity. Diabetics 
are at increased risk of myocardial ischaemia, cerebrovascular infarction and renal 
ischaemia because of their increased incidence of coronary artery disease, arterial atheroma 
and renal parenchymal disease. Increased mortality is found in all diabetics undergoing 
surgery and type I diabetics are particularly at risk of post-operative complications. 
Increased wound complications are associated with diabetes and anastomotic healing is 
severely impaired when glycaemic control is poor (Treiman, 1994; Verhofstad & Hendriks, 
1996; Zacharias & Habib, 1996). Type 2 diabetics not receiving insulin and undergoing 
minor surgery usually can be managed satisfactory without insulin. However, diabetic 
patients scheduled for major surgery, who are receiving hypoglicaemic medication or who 
have poor glycaemic control, should be established on insulin therapy preoperatively. 
Continuous i.v. infusion of insulin is a better option than intermittent s.c. bolus regimens 
and may be associated with improved outcome. The immediate perioperative problems 
facing the diabetic patient are: a) surgical induction of the stress response with catabolic 
hormone secretion; b) interruption of food intake, which will be prolonged in PC surgery; c) 
circulatory disturbances associated with anesthesia and surgery, which may alter the 
absorption of subcutaneous insulin. Surgery evokes the “stress response”, that is the 
secretion of catecholamines, cortisol, growth hormone and, in some cases, glucagone. These 
hormones oppose glucose homeostasis, as they have anti-insulin and hyperglicaemic effects. 
Although diabetics need increased insulin during the perioperative period, requirements for 
glucose and insulin in this period are unpredictable and close monitoring is essential, 
especially in the unconscious or sedated patients. The main concern for the anesthetist in the 
perioperative management of diabetic patients has been the avoidance of harmful 
hypoglicaemia; mild hyperglicaemia has tended to be seen as acceptable. High-dose opiate 
anesthetic techniques produce not only haemodinamic, but also hormonal and metabolic 
stability. Abolition of the catabolic hormonal response to surgery will abolish the 
hyperglicaemia seen in normal patients and may be of benefit in the diabetic patients. Tight 
metabolic control in the perioperative period is imperative and is a goal which is attainable 
in most patients. IV infusion of insulin is the standard therapy for the perioperative 
management of diabetes, especially in type 1 diabetic patients and patients with type 2 
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diabetes undergoing major procedure (Clement et al., 2004). Institutions around the world 
use a variety of insulin infusion algorithms that can be implemented by nursing staff. 
Recently, several insulin infusion protocols have been reported in the literature. Two main 
methods of insulin delivery have been used either combining insulin with glucose and 
potassium in the same bag (GIK regimen) or giving insulin separately with an infusion 
pump. The GIK is initiated at a rate of 100 mL/h in a solution of 500 mL of 10% dextrose, 10 
mmol of potassium, and 15 U of insulin. Adjustments in the insulin dose are made in 5 U 
increments according to blood glucose measurements performed at least every 2 hours. The 
combined GIK infusion is efficient, safe and effective but does not permit selective 
adjustment of insulin delivery without changing the bag. Separate continuous glucose and 
insulin infusions are used more frequently than the glucose-potassium-insulin infusion 
(Coursin et al., 2004; Furnary et al., 2003; Goldberg et al., 2004; Rehman & Mohammed, 
2003). A proposed regimen for separate IV insulin infusion for perioperative diabetes 
management is shown in Table 2. 
I) Initiating continuous insulin infusion (CII): 
Prepare solution: 1 unit (U) per 1 mL of 0.9% normal saline. 
Start continuous insulin infusion (CII) when blood glucose level ≥140 mg/dL (x 2). 
Patients with known diabetes treated with insulin can start CII when blood glucose ≥70 
mg/dL. 
Initial rate: divide blood glucose level (mg/dL) by 100, then round to nearest 0.5 U 
 
II) Insulin infusion rate change: 
BloodGlucose (mg/dL) instructions: 
>200  ↑rate by 2 U/h 
>160–200 ↑rate by 1.0 U/h 
>120–160 ↑rate by 0.5 U/h 
80–120  No change in rate 
60–80 If <10% lower blood glucose, rate by 1 U/h, 
  Check BG within 30 min 
  If >10% lower blood glucose, 2 rate by 50%, 
  Check BG within 30 min 
< 60  Stop infusion (give IV dextrose 12.5 g IV bolus), 
  Check blood glucose within 30 min. When blood glucose>100 mg/dL,  
  restart infusion at 50% of previous rate 
 
III) Patient monitoring: 
Check capillary blood glucose every hour until it is within goal range for 2 hours, and 
then decrease to every 2 hours. 
Hourly monitoring may be indicated for critically ill patients even if they have stable 
blood glucose. 
If a patient is eating, hourly blood glucose monitoring is necessary for at least 3 hours 
after eating. 
Decrease insulin infusion rate by 50% if nutritional therapy (e.g. total parenteral nutrition 
or tube feeds) are discontinued or significantly reduced. 
Table 2. Continuous insulin infusion (CII) protocol 
www.intechopen.com
 
Anesthesia and Pain Management: Techniques and Practice 
 
181 
2.3 Nutritional status 
Malnurished patients who require major operations are predisposed to infectious 
complications and poor outcome. A low preoperative body mass index (BMI, kg/m2) may 
be regarded as an overall indicator of the size of the patient’s reserves; a BMI<20 kg/m2 is 
an accepted indicator of malnutrition. However, it has been recognized that acutely 
malnourished patients may still have a normal or even elevated BMI. Serum protein 
markers such as albumin (for evaluating long-term nutritional status) and prealbumin (for 
evaluating acute responses to nutritional support) have been shown to be useful additional 
measurements for assessing nutritional status. Low albumin levels have been identified as an 
independent risk factor for postoperative morbidity and mortality (Gibbs et al., 1999). It should 
be emphasized that, although preoperative enteral or parenteral nutritional support clearly 
benefits surgical cancer patients, a systematic review showed that “preventive” administration 
of parenteral support in non-malnourished patients did not positively influence outcome and 
may even be potentially harmful for certain patient subgroups (Koretz et al., 2001). More 
recently, the concept of immunonutrition has evolved, in which enteral formulas are 
supplemented with arginine and glutamine, nucleotides or omega-3 fatty acids in an attempt 
to positively modulate the immune system, but the benefits of immunonutrition remain 
debatable. Where as perioperative nutrition in the malnourished patient can improve 
postoperative outcome, immunonutrition seems to attenuate the inflammatory response and 
interferes with certain immune functions in selected patient groups. 
2.4 Patient with jaundice 
Jaundice results from an abnormally high bilirubin in the blood whose origin may be   
difficulty in eliminating; it’s then an obstructive jaundice. This is the most symptom in 
patients with periampullary cancer (located near the Vater’s ampulla) or cancer of the 
pancreatic head. It can be considered  a risk factor for postoperative complications. [8, 9] 
Many studies demonstrate that it could be associated with a higher incidence of insufficient  
postoperative renal function, but also of sepsis, haemorrhage,  of liver failure and risk of 
mortality from  about 16% (Jiang & Puntis, 1997).  Jaundice causes a retention of acids and  
bile salts.   In the long term, may cause ascending cholangitis  and secondary hepatocellular 
damage. In case of interruption of bile flow, bile acids and salts can’t inhibit the 
phenomenon of translocation and endotoxemia caused by gram-negative from the digestive 
tract. These bacteria will then multiply and, for a  phenomenon of translocation, can 
contribute to the dissemination of endotoxins into the systemic circulation then creating a 
pro-inflammatory state with production of cytokines by activated macrophages and a 
subsequent risk of multiple organ failure, including the appearance of coagulation 
disorders. Since surgery in patients with jaundice is thought to increase the risk of 
postoperative complications, preoperative biliary drainage was introduced to improve the 
postoperative outcome. In several experimental studies preoperative biliary drainage 
reduced morbidity and mortality after surgery (Van der Gaag et al., 2009). In a multicentre, 
randomized trial, Van der Gaag et al compared preoperative biliary drainage with surgery 
alone for patients with cancer of the pancreatic head and they found that endoscopic 
preoperative drainage with placement of a plastic stent did not have a beneficial effect on 
the surgical outcome and early surgery without preoperative drainage did not increase the 
risk of complications (Van der Gaag, 2010). The preoperative oral administration of bile salts 
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or lactulose has been proposed in order to reduce the risk of endotoxemia by blocking 
bacterial translocation phenomenon from the gut. The effectiveness of this practice has not 
been validated. Anti-inflammatory and antibiotic prophylaxis should be avoided. In severe 
cases, a preoperative hemodiafiltration session can address the surgery with more serenity. 
2.5 The general physical examination 
The physical examination should be thorough but focused. Special attention is directed 
toward evaluation of the airway, heart, lungs and neurologic status.  
2.5.1 Vital signs and head and neck 
Height and wheight are useful in estimating drug dosages and determining volume 
requirements and the adequacy of perioperative urine output. Ideal body weight should be 
calculated in obese patients to help determine proper drug dosages and ventilator settings 
(e.g. tidal volume). Blood pressure should be recorded in both arms and any disparity noted 
(significant differences may imply disease of the thoracic aorta or its major branches). At 
same time should be observed and noted the respiration rate and oxygen saturation. One 
should evaluate maximal mouth opening, the size of the tongue, the ability to visualize the 
posterior pharyngeal structures and Mallampati classification. A thyromental distance 
shorter or longer than three fingerbreadth may be a sign of a difficult intubation. 
2.6 Laboratory studies  
A routine laboratory screening tests are necessary to evaluate a recent hematocrit/ 
hemoglobin level, the platelet activity and the coagulation status before surgery. An ECG 
should be obtained in any patient with risk factors for coronary artery disease (CAD). It can 
also detect new dysrhythmias and be useful to evaluate the stability of known abnormal 
rhythms. A chest radiography should be obtained in all patients to evaluate the 
cardiovascular image and to document any tracheal deviation or cervical masses. 
3. Anaesthetic management 
General anesthesia with mechanical ventilation is the rule. Spinal anesthesia is impractical 
owing to the length of the operation. However, epidural analgesia could, in theory, be used 
as the sole anesthetic technique. It’s our belief that the length of surgery, insertion of central 
lines and the high likelihood of conversion to general anesthesia make epidural alone 
unsatisfactory. Epidural analgesia may be beneficial post-operatively in reducing venous 
thromboembolic events, the incidence of respiratory failure and in providing superior 
analgesia in comparison with opioids. However, there may be clotting abnormalities 
perioperatively leading to an increased risk of neurological complications. Epidural can 
make assessment of the patient’s volume status more difficult and, with large fluid shifts 
occurring in this group, a period of hypovolemia could be worsened by concomitant 
vasodilatation secondary to the epidural analgesia. A balance of these risks needs to be 
addressed before embarking on an epidural anesthesia technique. It’s our practice to 
routinely use epidural analgesia as a part of combined general and regional technique in 
these patients. Postoperative analgesia is then provided by a catheter left in place in 
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epidural space. The choice of anesthetics must consider the interference pharmacokinetic: 
benzodiazepines should be avoided for premedication; propofol are the preferred induction 
agent; morphine should be used with caution in patients with hepatic or renal function 
(accumulation); muscle relaxants not metabolized by hepatobiliary system (atracurium, cis-
atracurium) are to be used in the first intent with adequate monitoring. The antibiotic 
prophilaxis (Enterobacteriaceae  and Staphylococcus) is essential in this surgery. Fluid and 
volume therapy is an important cornerstone of treating critically ill patients in the operating 
room. New findings concerning the vascular barrier, its physiological functions and its role 
regarding vascular leakage have lead to a new view of fluid and volume administration. 
Avoiding hypervolemia, as well as hypovolemia, plays a pivotal role when treating patients 
both perioperatively and in the intensive care unit. The postoperative phase may be studded 
with complications: sepsis, hepatic dysfunction, coagulation and metabolic disorders, renal 
and pulmonary failure and, in addition to the typical risks associated with abdominal 
surgery, some specific to the Whipple procedure, the two most common are pancreatic 
fistula and delayed gastric emptying (Buchler et al., 2003). Therefore the recovery in the 
postanesthesia care unit (PACU) is necessary for these fragile patients. 
3.1 Pharmacology of anesthetics 
3.1.1 Benzodiazepines 
Pre-, intra-and postoperative use of benzodiazepines (BZP) is widely not recommended 
because of their hepatic metabolism that exposed to an increased half-life, an extension the 
duration of action and delayed recovery. In premedication for anxiolysis, with the exception 
of jaundiced patients, midazolam 0.1-0.4 mg/Kg is indicated; after i.v. administration, the 
onset of central nervous system effects occurs in 2 to 3 minutes. BZP enhance inhibitory 
neurotransmission by increasing the affinity of GABAA receptors for GABA . Effects are 
terminated by redistribution, the metabolism is tipically hepatic and renal the elimination. 
Administration of a BZP to a patient receveing the anticolvulsivant valproate may 
precipitate a psychotic episode. 
3.1.2 Induction agents 
Thiopental has no longer the place it has had for very many years. In addition, its use was 
largely dissuaded in the presence of hepatobiliary disease because of its hepatic metabolism 
(cytochrome P450). Thiopental is metabolized to pentobarbital, an active metabolite with a 
longer half- life. Its use therefore exposed to delayed awakening. Similar to propofol, 
barbiturates facilitate inhibitory neurotransmission by enhancing GABAA receptor function. 
They also inhibit exicitatory neurotransmission via glutamate and nicotinic acetylcholine 
receptors. Absolutely contraindicated in patient with acute intermittent porphyria, variegate 
porphyria and hereditary coproporphyria (barbiturates induce porphyrin synthetic enzymes 
such as δ-aminolevulinic acid synthetase). Ketamine for its variable pharmacokinetics in the 
presence of extrahepatic biliary obstruction and postoperative hallucinatory effects has a 
limited use in clinical practice. Propofol is the agent of choice, not only for the induction, but 
also for sedation in patients requiring postoperative ventilatory support. It has a short action 
effect and the rapid metabolism is not influenced in the presence of liver failure. It is 
prepared as a 1% isotonic oil-in water emulsion, which contains egg lecithin, glycerol and 
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soybean oil. Bacterial growth is inhibited by ethylenediaminetetraacetic acid (EDTA), 
diethylenetriaminepentaacetic acid (DPTA), sulfite, or benzyl alcohol depending on the 
manufacturer (don’t use opened propofol after 6 hours to prevent inadvertent bacterial 
contamination). Mode of action: facilitation inhibitory neurotransmission by enhancing the 
function of GABAA receptors in the central nervous system; the modulation of glycine 
receptors, N-etyl-D aspartate receptors, cannabinoid receptors and voltage-gated ion 
channels may also contribute to propofol’s actions. After the infusion it can be observed 
dose–dependent decreases in preload, afterload and contractility that lead to decrease in 
blood pressure and cardiac output. Hypotension may be marked in hipovolemic, elderly, or 
hemodynamically compromised patients. Heart rate is minimally affected and baroreceptor 
reflex is blunted. Adverse effects are: venous irritation, lipid disorders, myoclonus and 
hiccups, “propofol infusion syndrome”. 
3.1.3 Opioids 
Morphine and its derivatives are essential for the perioperative period (commonly used in 
general anesthesia)  and are frequently used to ensure postoperative analgesia. Opioids, 
including morphine and fentanyl, have been accused to increase the bile ducts tone and to 
determine a spasm of Oddi’s sphincter. However, the consequences in clinical practice are 
limited: the pressure is most often in the bile duct within normal limits and the delay of the 
bile’s drainage  in the duodenum is not significant. Opioids differ in their potencies, 
pharmacokinetics and site effects. The mode of action is due to the interaction with specific 
receptors in the brain, spinal cord and peripheral neurons (Kumamoto et al., 2011). After i.v. 
administration, the onset of action is within minutes for the fentanyl derivatives; due to their 
lower lipid solubility hydromorphone and morphine may take from 20 to 30 minutes for 
their peak effect. Elimination is primarily by the liver and depends on hepatic blood flow. In 
patients with renal failure, the accumulation of morphine -6- glucuronide, the active 
metabolite, may cause prolonged narcosis and respiratory depression. Fentanyl is 
metabolized by hydrolysis and N-dealkylation  and its metabolites are excreted in the urine.  
Function  liver in the normal range is necessary to  plasma clearance in case of repeated 
injections. The pharmakocinets of alfentanil is also changed, with a  longer duration of 
action and an initial effect over pronounced. The sufentanil phamacokinetics is not altered 
even in cases of moderate hepatic insufficiency.  The short duration of action of remifentanil 
(context-insensitive half-time) and especially its extrahepatic metabolism (by non specific 
esterases in tissues, primarily skeletal muscle) are purely an advantage (Dershwitz et al., 
1996). Opioids exert emetogenic effects and represent a significant cause of patient 
discomfort. Nausea and vomiting can occur because of the direct stimulation of the 
chemoreceptor trigger zone, of the vestibular apparatus, inhibition of gut motility (Porreca 
& Ossipov, 2009). 
3.1.4 Halogenated 
Inhalation agents represent a basic drug used in modern balanced anesthesia. Actually the 
most important halogenated in the clinical use are sevoflurane and desflurane. They were 
developed in the late 1960s and tested in clinical practice much later. Sevoflurane was not 
immediately introduced to the USA because of its fluorine release and its reaction with 
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absorbed carbon dioxide. After several years of clinical application, no renal failure was 
observed and appropriate studies on compound A did not show any renal effects in human. 
Desflurane is largely appreciated for its high stability. Less than 0.02% of desflurane is 
metabolized, thus, plasma fluorine levels are very low. The very low solubility of desflurane 
allows for a surprisingly rapid emergence from anesthesia. Nitrous oxide has a controversial 
role in the modern anesthesia. For one and a half centuries it has played a relevant role in 
general anesthesia. Many of the side effects of nitrous oxide correlate with its physical 
properties. Its ability to diffuse into air filled cavities increases the likelihood of 
pneumothorax, air emboli and pressure in the cuff of the endotracheal tube. Nitrous oxide 
diffusion causes an increase in the middle ear pressure and distension of the bowel, possibly 
resulting in increases in postoperative nausea and vomiting. The results of a questionnaire 
proposed by the Association of Anesthesist of Great Britain and Ireland indicate that 49% of 
anesthesist had reduced their use of nitrous oxide (Henderson et al., 2002). According to 
Baum, nitrous oxide should not be used routinely as a carrier gas and the safer mixture of 
oxygen/medical air is able to replace this old anesthetic with some economical advantages 
(Baum, 2004). The combination of halogenated agents with short acting opioids results in the 
possibility of limiting the clinical application of nitrous oxide. Attempts to replace nitrous 
oxide with other gases has led to an increase in studies on xenon. This inert gas does not 
undergo metabolic biotransformation and has no direct negative environmental effects. 
Xenon has a very low solubility in the blood and its potency is higher when compared to 
nitrous oxide solubility (Hecker et al., 2004). Xenon cannot be synthesized and the available 
amount is very low. Consequently, at present, the cost of compound may be a limiting factor 
for the clinical use. The pharmacokinetic advantages of inhalation anesthetics are unique. By 
increasing or decreasing their inspired concentration, it is possible to increase or decrease 
their concentration in the blood and tissues, allowing for rapid changes in anesthesia depth 
and providing a simple method for inducing, maintaining and reversing general anesthesia. 
The flexibility of inhalation anesthesia cannot be reproduced with modern intravenous 
hypnotics or opioids. Furthermore, it is important to underline the protective effects of 
inhalation agents on several different organs. 
3.1.5 Neuromuscolar blocking drugs 
Non depolarizing blockade is produced by reversible competitive antagonism of Ach at the 
α subunits of the AChRs. The principal pharmacologic effect is to interrupt transmission of 
synaptic signaling at the neuromuscular junction. The neuromuscular blocking agents in 
biliary excretion (e.g. vecuronium) should be avoided in favor of those metabolized by  
way of Hoffman (atracurium, cis-atracurium). In all cases, the use of a monitoring of 
neuromuscular blockade is obviously essential (Chiu & White, 2000; Murphy & 
Szokol,2004). 
3.2 Monitoring 
Standard monitoring for general anaesthesia involves oxygenation (analyzer and pulse 
oximetry), ventilation (capnography and minute ventilation), circulation (ECG with ST- 
segment analysis, blood pressure and perfusion assessment) and temperature if necessary. 
Additional monitoring may be added such as invasive arterial and venous pressure 
www.intechopen.com
 
Pancreatic Cancer – Clinical Management 
 
186 
monitoring, trans esophageal echocardiography (TEE), neuromuscular blockade and central 
nervous system monitoring. Automated noninvasive blood pressure is the most common 
noninvasive method of measuring blood pressure in the operating room for minor surgery. 
Invasive blood pressure (IBP) monitoring is imperative in the pancreatic surgery; there is 
potential for rapid swings in blood pressure and acid-base balance often needs managing 
(acidosis is common). IBP uses an indwelling arterial catheter coupled through fluid-filled 
tubing to a pressure transducer. The transducer converts pressure into a electrical signal to 
be displayed. Generally the catheter size is 18 to 20 gauge for adults. The radial artery is the 
most common site. Other locations include ulnar, brachial, axillary, femoral and dorsal 
pedis arteries. The procedure should be perfomed aseptically. Local anesthetic may be used 
to raise a skin wheal if the patient is awake. For catheter insertion it can be used the 
Seldinger technique. The modified Allen test has been recommended to assess the relative 
patency and contribution of the radial and ulnar arteries to the blood supply to the hand, 
but the results are unreliable. Central venous catheter (CVC) is essential; ultrasound 
guidance can be useful in the patients that have had multiple previous cannulation. The 
central venous pressure (CVP) and cardiac output (CO) are monitored by CVC. CVP is 
measured by coupling the intravascular space to a pressure transducer using a fluid-filled 
tubing. Pressure is monitored at the level of the vena cava or the right atrium. The normal 
CVP is 2 to 6 mmHg. Positive- pressure ventilation affects both cardiac output and venous 
return. According to the Starling rule, the transmural pressure, which is the difference 
between the atrial pressure and extracardiac pressure, correlates with the cardiac output. At 
low level of PEEP, the CVP increases with increased PEEP, at high levels of PEEP (over 15 
cmH2O), CVP increases as the cardiac output is depressed because of impaired right 
ventricular output. Common locations include internal jugular and subclavian vein. 
Multiple lumen catheters are directly inserted and are available with one to four lumens to 
provide access for multiple drugs, pressure monitoring and blood sampling. Temperature 
may be measured continuously; the limitation of more external methods of temperature 
determination is that they may not reflect changes in the core body temperature, especially 
in the presence of vasoconstriction. Oropharyngeal temperature monitoring is preferred in 
any lengthy laparotomy, which has potential for blood loss and perioperative clotting 
abnormalities. Ventilation is assessed by end- tidal carbon dioxide measurements and 
spirometry. Capnometry and capnography are often used as synonyms, as both analyze and 
record carbon dioxide, with the latter including a waveform. Capnography not only 
evaluates respiration but also confirms of endotracheal intubation and its diagnostic of 
pathologic conditions. Neuromuscular blockade is utilized, above all for patients with co-
existing renal failure. The adductor pollicis response to ulnar nerve stimulation at the wrist 
is most often used, because it is easily accessible, and the results are not confused with direct 
muscle activation. Cutaneous electrodes are placed at the wrist over the ulnar nerve and 
attached to a battery-driven pulse generator, which delivers a graded impulse of electrical 
current at a specified frequency. For maximal twitch response, the negative pole (active) 
should be placed distally over the ulnar nerve at the wrist. Evoked muscle tension can be 
estimated by feeling for thumb adduction or measured by using a force transducer attached 
to the thumb. After administration of a neuromuscular blocking drug (NMBD), the 
developed tension and twitch height decrease with the onset of blockade. Foley catheter is 
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the rule in all patient ones, necessary for fluid management and the control of the renal 
functionality. 
3.3 Conduct of anaesthesia 
The primary goals of general anesthesia are to maintain the health of the patient while 
providing amnesia, hypnosis (lack of awareness), analgesia and immobility. Secondary 
goals may vary depending on the patient’s medical condition and the surgical procedure. 
Perioperative planning involves the integration of preoperative, intraoperative and 
postoperative care. Flexibility, the ability to anticipate problems before they occur and the 
ability to execute contingency plans are skills that define the expert anesthetist. An 
anesthetic plan developed prior to entering the operating room helps the anesthetist 
marshal appropriate resources and anticipate potential difficulties. Important elements to 
consider in the anesthetic plain include: risk assessment (ASA classification), specific 
homeostatic challenges, intravenous access, monitoring, airway management, medications, 
perioperative analgesia, postoperative transport and disposition. Preoperative medications 
is realized with midazolam 0.1-0.4 mg/Kg (except cases of jaundice) for anxiety control. It is 
also important to consider aspiration prophylaxis; drugs to neutralize gastric acid and 
decrease gastric volume are used: metoclopramide 10 mg and ranitidine 50 mg usually. 
Induction of anesthesia produces an unconscious patient with depressed reflexes who is 
dependent on the anesthetist for maintenance of homeostatic mechanisms and safety. The 
patient’s position for induction is usually supine, with extremities resting comfortably on 
padded surface in a neutral anatomic position. The head should rest comfortably on a firm 
support, which is raised in a “sniff” position. Routine pre-induction administration of 
oxygen minimizes the risk of hypoxia developing during induction of anesthesia. High flow 
(8 to 10 L/minute) oxygen should be delivered via a face mask placed gently on the 
patient’s face. Commonly, for the induction of anesthesia, we use propofol 4-6 mg/Kg, a 
non- depolarizing neuromuscular blocking agent (cis–atracurium 0,15 mg/Kg is the usual 
choice) and sufentanil 0.1-0.5 mcg/Kg. Hypertensive patients may have an exaggerated 
pressor response to laryngoscopy. To obtund this response, opioids or β-blockers can be 
used. Tracheal intubation is performed with laryngoscopy usually. An appropriate ETT size 
depends on the patient’s age, body habitus. Proper placement of the ETT needs to be 
verified by the detection of carbon dioxide in end-tidal or mixed expiratory gas as well as 
inspection and auscultation of the stomach and both lung fields during positive-pressure 
ventilation. Tidal volumes of 8-10 ml/ Kg and a respiratory rate of 10 to 12 breaths/minute 
are set and low level PEEP is beneficial. For the maintenance of anesthesia we use normally 
a mixture of oxygen and air (40%/60%) and an halogenated (sevoflurane or desflurane) with 
a continuous infusion of sufentanil until the end of operation. The infusion of sufentanil 
generally is continued in the PACU to better adapt the patient to the mechanical ventilation. 
If we decide for a blended anesthesia, before the induction of anesthesia, we perform a 
thoracic epidural anesthesia (T8-T10) with the patient in sitting position. 
3.4 Epidural anaesthesia / analgesia 
The epidural space is surrounded by the outer surface of the dura mater and the bony and 
ligamentous walls of the spinal canal and extends from the foramen magnum to the sacral 
hiatus. The cross-sectional area of the epidural space becomes smaller cranially, as the theca 
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and its contents tend to occupy a greater proportion of space. Hence, a given volume of 
drugs affects a greater number of segments the more cranially it is introduced. The epidural 
space contains nerve roots, fat, spinal arteries and lymphatics, as well as a valveless venous 
system that communicates directly with both the intracranial sinuses via the basovertebral 
veins and the general circulation via the azygos vein. Dorsal and ventral spinal nerve roots 
covered by dura mater pass across the epidural space and drugs within this space can act on 
any nerve that traverses it – whether it be motor, sensory or autonomic. Epidural analgesics 
may prevent the release of neurotransmitters from afferent pain fibres, block receptors to 
neurotransmitters released by primary afferent pain fibres or interrupt the transmission of 
pain-related information in the dorsal horn of the spinal cord. Drugs introduced into the 
epidural space also have the potential to pass into the brain and the general circulation 
depending on their pharmacokinetics. Epidural analgesia was originally achieved with local 
anaesthetic agents but, more recently, with opioids or a combination of local anaesthetics 
and opioids. This combination has a synergistic action that allows the concentration of each 
drug to be reduced, thereby limiting unwanted effect produced by higher concentrations. 
Ketamine, midazolam or clonidine has also been used in combination with local anaesthetics 
and opioids to obtain the best intra- and post-operative pain control. Local anaesthetics 
penetrate axonal membranes within the epidural space and bind to sodium channels in 
nerves. This inhibits sodium conductance and reduces action potential depolarization, 
thereby reducing nerve stimulus propagation. The drawback is that the effect is non 
selective, involving both autonomic and somatic nerves. Thinner nerve fibres are affected by 
lower local anaesthetic concentrations than thicker fibres, suggesting that neuronal block is a 
function of diameter. With increasing local anesthetic concentration, the thinner C fibres 
(pain and autonomic fibres) are blocked first, followed by B fibres (preganglionic 
sympathetic fibres) and finally the largest A fibres (touch, pressure sensation and motor 
fibres). Epidural analgesia aims to produce a differential nerve block, affecting 
predominantely nociceptive fibres with few motor effects. Opioids act on opioid receptors 
that are widespread throughout the nervous system, but more concentrated in the 
medullary dorsal horn of the spinal cord and the periaqueductal grey matter of the brain. 
Opioid receptors belong to the family of guanine nucleotide-binding protein receptors. They 
exist as three principle types (OP1, OP2 and OP3) and opioids acting at these receptors have 
the advantage of selectively blocking pain without affecting motor function or the sense of 
touch. Epidural opioids act mainly on presynaptic and postsynaptic receptors in the 
substantia gelatinosa of the dorsal horn of the spinal cord (Fotiadis et al., 2004). The 
combination of thoracic epidural analgesia (TEA) and general anesthesia has become a 
widespread anesthetic technique for the perioperative treatment of patients undergoing 
major abdominal surgery. The neuraxial application of local anesthetics and opioids 
provides superior pain relief, reduced hormonal and metabolic stress, enhanced 
normalization of gastrointestinal function and thus a shortened postoperative recovery 
time, facilitating mobilization and physiotherapy. TEA is currently thought to mitigate 
this effect by blocking nociceptive afferent nerves and thoracolumbar sympathetic efferent 
routes. In a very recent cohort study Van Lier F. et al. (Van Lier et al., 2011) demonstrated 
that epidural analgesia reduces postoperative pneumonia in patients with chronic 
obstructive pulmonary disease (COPD) undergoing major abdominal surgery. Among the 
long-acting local anesthetics, the S-enantiomer, ropivacaine, is gaining increasing 
preference for continuous epidural analgesia. Ropivacaine has lower central nervous 
system and cardiac toxicity and a less frequent incidence of motor block (differential 
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block) during mobilization than bupivacaine (Macias et al., 2002). Panousis et al. 
evaluated the effect of different epidurally administered concentrations of ropivacaine on 
inhaled anesthetic, fluid and vasopressor requirement and hemodynamic changes. They 
concluded that ropivacaine 0.5% compared with a ropivacaine 0.2 % concentration led to a 
greater inhaled anesthetic-sparing effect at the same levels of IV fuid supply and 
vasopressor support (Panousis et al., 2009). In a critical appraisal published on 2008, Pratt 
WB et al. concluded that although it may provide more effective initial pain control, 
epidural analgesia does not necessarily improve the critical outcome as after 
pancreatoduodenectomy. The Authors explained it with the high propensity for rapid 
fluid shifts and excessive blood loss during this operation, which may negate the 
proposed benefits of administering analgesic medications by epidural infusion and they 
reinforced these results considering the frequent need to terminate epidural infusions 
because of hemodynamic compromise or inadequate analgesia. Spinal epidural hematoma 
(SHE) after epidural analgesia is a rare but serious complication. Most cases of SHE after 
epidural block are attributed to a bleeding tendency or anticoagulant therapy. Placement 
of an epidural catheter may cause SHE more often than expected, but most SEHs remain 
asymptomatic (Inoue, 2002). The incidence of significant spinal bleeding (paraplegia 
requiring laminectomy) has been estimated at 1:1,000,000 in patients without clinically 
apparent coagulation disorders. Vandermeulen et al. found spinal bleeding immediately 
after removal of the epidural catheter in 15 of the 32 cases that he reviewed. Spontaneous 
SHE has been reported in a few cases (Skilton, 1998; Vandermeulen, 1994). The maximum 
incidence of clinically important spinal bleeding after epidural catheter blocks without 
specific additional risk factors probably list between 1:190,000-200,000. Approximately 60-
80% of all clinically important spinal bleeding is associated with haemostatic disorders or 
a blood tap. Removal of an epidural catheter should be considered a significant risk factor 
for spinal bleeding because 30-60% of clinically important spinal hematomas occurs after 
catheter removal (Tryba, 1998). A practical approach to the patients with 
anticoagulant/antiaggregant therapy is reported in Table 3, according to the last 
guidelines of the European Society of Anaesthesiology. 
Where central neural block is contraindicated (e.g systemic sepsis, in anti-coagulated 
patients), or where epidural catheterization is technically impossible, bilateral paravertebral 
nerve blocks (PVB) is a suitable alternative. The paravertebral space is a potential space, 
which is turned into a temporary cavity by fluid. Anaesthesia occurs because of direct 
penetration of local anesthetic (LA) into the neurological structures contained within the 
PVB (anterior and posterior ramus of the intercostals nerve, sympathetic chain, rami 
comunicantes, sinu-vertebral nerve). The spinal nerve, lacking both an epineurvium and 
part of the perinervium and with only a thin membranous root sheath is easily penetrated 
by LA and hence easily and efficiently blocked (Karmaker, 2001). We recommend the use of 
levobupivacaine or ropivacaine for bilateral blocks. Good preservation of postoperative 
pulmonary function has been demonstrated, particularly in thoracotomy, which is a 
significant benefit over epidural analgesia (Davies et al., 2006). The incidence of 
complications such as pneumothorax and hypotension is low. For bilateral PVB a variety of 
techniques, including loss of resistance, nerve  stimulators and ultrasound, have been used. 
Potential or relative contraindications to the use of PVB are: coagulation disordes, tumor in 
the PVB and empyema. The relationship of regional anaesthesia to wound healing, chronic 
postoperative pain, and cancer recurrence rates with this and other block is important. 
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Time before 
puncture/catheter 
manipulation or 
removal 
Time after 
puncture/catheter 
manipulation or 
removal 
Laboratory tests 
Unfractionated heparins 
(for prophylaxis, 
≤ 15 000 IU per day) 
4-6 h 1 h 
Platelets during 
treatment for 
more than 5 days 
Unfractionated heparins 
(for treatment) 
i.v. 4–6 h 
s.c. 8–12 h 
1 h 
1 h 
aPTT, ACT, 
platelets 
Low-molecular-weight 
heparins (for prophylaxis) 
12 h 4 h 
Platelets during 
treatment for 
more than 5 days 
Low-molecular-weight 
heparins (for treatment) 
24h 4h 
Platelets during 
treatment for 
more than 5 days 
Fondaparinux  
(for prophylaxis,  
2.5mg per day) 
36-42h 6-12h 
(anti-Xa, 
standardised for 
specific agent) 
Rivaroxaban (for 
prophylaxis, 10mg q.d.) 
22-26 h 4–6 h 
(PT, standardised 
for specific agent ) 
Apixaban (for prophylaxis, 
2.5mg b.i.d.) 
26-30 h 4–6 h ? 
Dabigatran (for 
prophylaxis, 150–220 mg) 
Contraindicated 
according to the 
manufacturer 
6 h ? 
Coumarins INR ≤1.4 after catheter removal INR 
Hirudins 
(lepirudin, desirudin) 
8-10 h 2-4 h aPTT, ECT 
Argatrobanc 4 h 2 h aPTT, ECT, ACT 
Acetylsalicylic acid None None  
Clopidogrel 7 days after catheter removal  
Ticlopidine 10 days after catheter removal  
Ticagrelor 5 days 
6 h after catheter 
removal 
 
Cilostazolc 42 h 
5 h after catheter 
removal 
 
Prasugrel 7-10 days 
6 h after catheter 
removal 
 
NSAIDs None None  
ACT, activated clotting time; aPTT, activated partial thromboplastin time; b.i.d., twice daily; ECT, ecarin clotting 
time; INR, international normalised ratio; IU, international unit; 
i.v., intravenously; NSAIDs, non-steroidal anti-inflammatory drugs; s.c., subcutaneously; q.d., daily. 
All time intervals refer to patients with normal renal function. Prolonged time interval in patients with hepatic 
insufficiency. 
Table 3. Recommended time intervals before and after neuraxial puncture or catheter 
removal (Gogarten et al., 2010) 
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3.5 Postoperative care 
3.5.1 Postoperative I.V. analgesia  
In patients with epidural catheter the analgesia can be continued with a volumetric or 
elastomeric pump with a rate infusion of 5-8 ml/h, by using local anesthetics alone or in 
combination with opioids. Generally we use ropivacaine 2mg/ml and sufentanil 5 mcg/ml. 
In patients where was impossible the positioning of an epidural catheter the postoperative 
analgesia is performed with NSAIDs or opioids or mixture of them. Several protocols are 
reported in literature for IV analgesia, but generally morphine is the leader drug. The 
patient controlled analgesia (PCA) is the best route of administration with a primary dose of 
2-10 mg and a rescue dose of 0.5-2 mg with a lock-out of 5-10 minutes (Miaskowski, 2005). A 
specific role have the COX-2 inhibitors. Parecoxib (40-80 mg) is disposable for intravenous 
administration (Nussmeier et al, 2006).  
3.6 Pain and inoperable pancreatic cancer 
Pancreatic diseases such as cancer can cause clinically significant pain in the upper 
abdomen, which may radiate to the back. Pain management for pancreatic cancer patients is 
one of the most important aspects of their care, as it is one of the most weakening 
symptoms. The best therapy involves adequate therapy with constant assessment. The 
current management of pancreatic pain follows the WHO three-step ladder for pain control, 
starting with non-opioid analgesics such as nonsteroidal anti-inflammatory drugs (NSAIDs) 
and progressing to increasing doses of opioid analgesics (WHO, 2008). For pain that does 
not respond to drugs, or when oral or topical medication leads to unacceptable side effects 
such as nausea, constipation, somnolence, confusion, dependence and addiction, an alcohol 
nerve block can be indicated. This provides pain relief by acting directly on the nerves 
(celiac plexus) that carry painful stimuli from the diseased pancreas to the brain. Pancreatic 
cancer causes severe pain in 50% to 70% of patients. This kind of pain is multi-factorial 
(pancreatic duct obstruction and hypertension, neural invasion) and it is often difficult to 
treat (Staatas 2001). Different mechanisms perpetuate pancreatic pain: infiltration of nerve 
sheaths and neural ganglia, increased ductal and interstitial pressure and gland 
inflammation. Pancreatic pain is generally transmitted through the celiac plexus, a neural 
structure located in the upper abdomen, near the emergence of the celiac trunk from the 
aorta. Celiac plexus neurolysis was first described by Kappis (1919) and is done at the level 
of the L1 vertebral body, with the patient in the prone position. There are a number of 
variations on the technique (Giménez, 1993). It has been described in the literature since the 
1950s but the first prospective study was published in 1990 and the first randomized in 1992. 
Celiac plexus neurolysis can be done surgically under fluoroscopic guidance or under 
computed tomography (CT) guidance. The target for celiac axis destruction are the 
splanchnic nerves and/or celiac ganglia. The splanchnic nerves cross the diaphragm, enter 
the abdominal cavity and form the celiac plexus. The celiac ganglia are located around the 
celiac artery anterior to the aorta, in varying positions, from T12 to L2. They can be reached 
percutaneously by different routes, with one needle through the anterior approach (under 
CT or ultrasound guidance) or with one or two needles through the posterior approach. 
During abdominal surgical procedures for pancreatic cancer chemical splanchnicectomy can 
be achieved by injecting the neurolytic solutions directly into the junction area of the 
splanchnic nerves with the celiac ganglia in the retroperitoneal area. With the advent of 
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endoscopic ultrasonography (EUS) new therapeutic applications for endoscopy have been 
developed and a needle can now be guided safely in the celiac plexus (Puli, 2009). The celiac 
plexus is destroyed by alcohol injected under the guidance of real-time endosonography. 
First, using a linear array echo-endoscope, the region of the celiac ganglia is located from the 
lesser curve of the stomach, following the emergence of the celiac trunk from the aorta. The 
anterior approach avoids the retro-crural space and minimizes the risk of neurologic 
complications such as paraesthesia or paralysis. Anyway, although statistical evidence is 
minimal for the superiority of pain relief over analgesic therapy, the fact that CPB causes 
fewer adverse effects than opioids is important for patients.  
4. Conclusion 
Pancreatic ductal adenocarcinoma (90% of pancreatic cancers) remains a devastating 
disease. For a select group in which complete resection is possible, surgery prolongs 
survival. Pancreaticoduodenectomy, the “Cadillac” of abdominal operations, is a major 
surgery with significant morbidity and mortality. The pancreatico-enteric anastomosis has 
been the Achilles’ heel of this operation. Adequate nutritional support, reduction of 
invasiveness, shorter operation times, combined regional/general anesthesia, and target-
controlled fluid management are options for reducing postoperative morbidity. In recent 
decades, diagnostic modalities and the surgical and palliative treatments of PC have clearly 
progressed, although the overall prognosis has barely changed. The management of patient 
affected by PC is complex and requires exepertise in many fields. Multidisciplinary teams 
are necessary to optimize the overall care. The anesthesiologist plays a crucial role in the 
perioperative management of such patients and for patient with unresectable PC (anesthesia 
and analgesia). Careful patient selection, individualized preoperative evaluation and 
optimization go a long way in improving the short-term and long-term outcomes of these 
patients. In the future new protocols are necessary for pain control, adjuvant strategies, 
palliative measures in patients with pancreatic cancer. 
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